Study Assessing the PK of EFB0027 and Effect on Circulating Glucose and GI Hormone Concentrations in Subjects With T2DM

This study has been completed.
Information provided by (Responsible Party):
Elcelyx Therapeutics, Inc. Identifier:
First received: August 23, 2012
Last updated: August 14, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)